Summary
Data from the Randomized, Double-Blind Study Comparing the Safety & Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, & Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis [PRESERVE; NCT00565409] show that patients with moderately active rheumatoid arthritis (RA) achieve and maintain low disease activity and remission with anti-tumor necrosis factor therapy more successfully than those with high RA activity [Keystone E et al. J Rheumatol 2009].
- rheumatoid arthritis clinical trials
- © 2011 MD Conference Express
Tools
PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
Permalink:
Table of contents
Cited By...
- No citing articles found.